| 1 |
Bonney EY, Lamptey H, Kyei GB. HIV cure: an acceptability scientific agenda. Curr Opin HIV AIDS 2023;18:12-7. [PMID: 36503877 DOI: 10.1097/COH.0000000000000771] [Reference Citation Analysis]
|
| 2 |
Mediouni S, Lyu S, Schader SM, Valente ST. Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors. Viruses 2022;14:1980. [DOI: 10.3390/v14091980] [Reference Citation Analysis]
|
| 3 |
Kálai T, Pongrácz JE, Mátyus P. Recent Advances in Influenza, HIV and SARS-CoV-2 Infection Prevention and Drug Treatment—The Need for Precision Medicine. Chemistry 2022;4:216-58. [DOI: 10.3390/chemistry4020019] [Reference Citation Analysis]
|
| 4 |
Wang X, Xu W, Liu Z, Wu Y, Wang Q, Cao M, Ying T, He N, Lu L, Jiang S. A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent Cells. mBio 2022;13:e0338421. [PMID: 35038908 DOI: 10.1128/mbio.03384-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 5 |
Magro G, Calistri A, Parolin C. Targeting and Understanding HIV Latency: The CRISPR System against the Provirus. Pathogens 2021;10:1257. [PMID: 34684206 DOI: 10.3390/pathogens10101257] [Reference Citation Analysis]
|
| 6 |
Cunha RF, Simões S, Carvalheiro M, Pereira JMA, Costa Q, Ascenso A. Novel Antiretroviral Therapeutic Strategies for HIV. Molecules 2021;26:5305. [PMID: 34500737 DOI: 10.3390/molecules26175305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 7 |
SenGupta D, Brinson C, DeJesus E, Mills A, Shalit P, Guo S, Cai Y, Wallin JJ, Zhang L, Humeniuk R, Begley R, Geleziunas R, Mellors J, Wrin T, Jones N, Milush J, Ferre AL, Shacklett BL, Laird GM, Moldt B, Vendrame E, Brainard DM, Ramgopal M, Deeks SG. The TLR7 agonist vesatolimod induced a modest delay in viral rebound in HIV controllers after cessation of antiretroviral therapy. Sci Transl Med 2021;13:eabg3071. [PMID: 34162752 DOI: 10.1126/scitranslmed.abg3071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 8 |
Wang Q, Su S, Xue J, Yu F, Pu J, Bi W, Xia S, Meng Y, Wang C, Yang W, Xu W, Zhu Y, Zheng Q, Qin C, Jiang S, Lu L. An amphipathic peptide targeting the gp41 cytoplasmic tail kills HIV-1 virions and infected cells. Sci Transl Med 2020;12:eaaz2254. [PMID: 32493792 DOI: 10.1126/scitranslmed.aaz2254] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 9 |
Cai Z, Gong Z, Li Z, Li L, Kong W. Vascular Extracellular Matrix Remodeling and Hypertension. Antioxid Redox Signal 2021;34:765-83. [PMID: 32460598 DOI: 10.1089/ars.2020.8110] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 10 |
Bonney EY, Lamptey H, Aboagye JO, Zaab-Yen Abana C, Boateng AT, Quansah DNK, Obo-Akwa A, Ganu VJ, Puplampu P, Kyei GB; H-CRIS Massive Action Team. Unwillingness of patients in Ghana to interrupt antiretroviral therapy for HIV cure research. J Virus Erad 2021;7:100027. [PMID: 33437495 DOI: 10.1016/j.jve.2020.100027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? J Virus Erad 2020;6:100017. [PMID: 33251025 DOI: 10.1016/j.jve.2020.100017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Martín-Moreno A, Jiménez Blanco JL, Mosher J, Swanson DR, García Fernández JM, Sharma A, Ceña V, Muñoz-Fernández MA. Nanoparticle-Delivered HIV Peptides to Dendritic Cells a Promising Approach to Generate a Therapeutic Vaccine. Pharmaceutics 2020;12:E656. [PMID: 32664555 DOI: 10.3390/pharmaceutics12070656] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 13 |
Li GH, Maric D, Major EO, Nath A. Productive HIV infection in astrocytes can be established via a nonclassical mechanism. AIDS 2020;34:963-78. [PMID: 32379159 DOI: 10.1097/QAD.0000000000002512] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 14 |
Singh AK, Salwe S, Padwal V, Velhal S, Sutar J, Bhowmick S, Mukherjee S, Nagar V, Patil P, Patel V. Delineation of Homeostatic Immune Signatures Defining Viremic Non-progression in HIV-1 Infection. Front Immunol 2020;11:182. [PMID: 32194543 DOI: 10.3389/fimmu.2020.00182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 15 |
Kalidasan V, Theva Das K. Lessons Learned From Failures and Success Stories of HIV Breakthroughs: Are We Getting Closer to an HIV Cure? Front Microbiol 2020;11:46. [PMID: 32082282 DOI: 10.3389/fmicb.2020.00046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 16 |
Martín-Moreno A, Muñoz-Fernández MA. Dendritic Cells, the Double Agent in the War Against HIV-1. Front Immunol 2019;10:2485. [PMID: 31708924 DOI: 10.3389/fimmu.2019.02485] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 17 |
Latinovic OS, Neal LM, Tagaya Y, Heredia A, Medina-Moreno S, Zapata JC, Reitz M, Bryant J, Redfield RR. Suppression of Active HIV-1 Infection in CD34+ Hematopoietic Humanized NSG Mice by a Combination of Combined Antiretroviral Therapy and CCR5 Targeting Drugs. AIDS Res Hum Retroviruses 2019;35:718-28. [PMID: 31099257 DOI: 10.1089/AID.2018.0305] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 18 |
Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, Chen C, Mancuso P, Sariyer R, Ferrante P, Donadoni M, Robinson JA, Sillman B, Lin Z, Hilaire JR, Banoub M, Elango M, Gautam N, Mosley RL, Poluektova LY, McMillan J, Bade AN, Gorantla S, Sariyer IK, Burdo TH, Young WB, Amini S, Gordon J, Jacobson JM, Edagwa B, Khalili K, Gendelman HE. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun 2019;10:2753. [PMID: 31266936 DOI: 10.1038/s41467-019-10366-y] [Cited by in Crossref: 151] [Cited by in F6Publishing: 162] [Article Influence: 37.8] [Reference Citation Analysis]
|
| 19 |
Newton L, Necochea R, Palm D, Taylor J, Barr L, Patel H, Nathan A, Gerrard J, Sylla L, Brown B, Dubé K. Revisiting the ‘sterilising cure’ terminology: a call for more patient-centred perspectives on HIV cure-related research. Journal of Virus Eradication 2019;5:122-4. [DOI: 10.1016/s2055-6640(20)30054-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 20 |
Newton L, Necochea R, Palm D, Taylor J, Barr L, Patel H, Nathan A, Gerrard J, Sylla L, Brown B, Dubé K. Revisiting the 'sterilising cure' terminology: a call for more patient-centred perspectives on HIV cure-related research. J Virus Erad 2019;5:122-4. [PMID: 31191916] [Reference Citation Analysis]
|
| 21 |
Zhang XX, Lin J, Liang TZ, Duan H, Tan XH, Xi BM, Li L, Liu SW. The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation. Acta Pharmacol Sin 2019;40:98-110. [PMID: 29789664 DOI: 10.1038/s41401-018-0027-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
| 22 |
Dangi AK, Sinha R, Dwivedi S, Gupta SK, Shukla P. Cell Line Techniques and Gene Editing Tools for Antibody Production: A Review. Front Pharmacol 2018;9:630. [PMID: 29946262 DOI: 10.3389/fphar.2018.00630] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 23 |
Hendricks M, Nair G, Staunton C, Pather M, Garrett N, Baadjies D, Kidd M, Moodley K. Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa. Journal of Virus Eradication 2018;4:103-7. [DOI: 10.1016/s2055-6640(20)30252-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 24 |
Hendricks M, Nair G, Staunton C, Pather M, Garrett N, Baadjies D, Kidd M, Moodley K. Impact of an educational video as a consent tool on knowledge about cure research among patients and caregivers at HIV clinics in South Africa. J Virus Erad 2018;4:103-7. [PMID: 29682302] [Reference Citation Analysis]
|
| 25 |
Gibellini L, Pecorini S, De Biasi S, Pinti M, Bianchini E, De Gaetano A, Digaetano M, Pullano R, Lo Tartaro D, Iannone A, Mussini C, Cossarizza A, Nasi M. Exploring viral reservoir: The combining approach of cell sorting and droplet digital PCR. Methods 2018;134-135:98-105. [PMID: 29197654 DOI: 10.1016/j.ymeth.2017.11.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 26 |
Yang W, Sun Z, Hua C, Wang Q, Xu W, Deng Q, Pan Y, Lu L, Jiang S. Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus. Microbes Infect 2018;20:626-34. [PMID: 29126877 DOI: 10.1016/j.micinf.2017.10.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 27 |
Mccarthy MW, Walsh TJ. Harnessing the potential of CRISPR-Cas9 to advance the study of human fungal pathogens. Expert Review of Precision Medicine and Drug Development 2017;2:295-301. [DOI: 10.1080/23808993.2017.1375851] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
